Tag: Concord Biotech
- 22 Sep
Concord Biotech Shares Up 3% on Positive Outlook from Analysts
Concord Biotech shares were trading 3% higher on September 22nd after Kotak Institutional Equities and Antique Broking initiated coverage of the company with a positive outlook on the stock. Both brokerages cited the company's expertise in high entry barrier fermentation active pharmaceutical ingredients (API) segment and strong underlying demand trends as key reasons for their bullish stance. Kotak Institutional Equities has an 'add' rating on the company's stock and has set a target price of Rs 1,110 per share, while Antique Brokings has a 'buy' rating and has set a target price of Rs 1,340 per share.
News Categories
Tag Cloud
Asian markets
Bank Nifty
Brokerage Recos - Currencies
Business
Buy
Buzzing Stocks
Commodities
Companies
Current Affairs
Economy
EMs
F&O Manual
ICICI Direct
India
IPO
IPO - Issues Open
IPO - News
IPO - Upcoming Issues
Local Markets
Market Cues
Market Edge
MARKET OUTLOOK
markets
Motilal Oswal
mutual funds
Nifty
Nifty Bank
Politics
Real Estate
Recommendations
RR Kabel
rupee
Sell
Sensex
Sharekhan
Signature Global
Slideshow
stocks in the news
Stocks Views
Taking Stock
Technicals
Technical View
USDINR
World News
Zaggle Prepaid Ocean Services